Takeda Gmbh, podružnica Slovenija
Takeda Pharmaceuticals is a leading global biopharmaceutical company dedicated to creating better health outcomes for individuals and contributing to a brighter future across the globe. With a strong focus on advancing science and technology, Takeda is committed to transforming lives through innovative medical solutions.
At Takeda, our mission is to drive the advancement of science and leverage it to deliver life-changing medicines. Our core values emphasize integrity, transparency, and a commitment to corporate responsibility, ensuring that we operate ethically and sustainably.
| Area of Focus | Description |
|---|---|
| Gastrointestinal and Inflammation | Understanding and addressing life-limiting gastrointestinal and inflammatory diseases. |
| Rare Diseases | Transforming treatment options in immunology, hematology, metabolic, and lysosomal storage disorders. |
| Plasma-Derived Therapies | Innovating to improve the lives of patients with rare and chronic conditions through plasma therapy. |
| Oncology | Aspiring to cure cancer by drawing inspiration from patients and fostering innovation. |
| Neuroscience | Focusing on medical innovations that cater to neurological diseases. |
| Vaccines | Addressing global health needs with innovative vaccine development for infectious diseases. |
Takeda is at the forefront of innovation, showcased through recent advancements such as the clearances received for devices simplifying medication administration and groundbreaking results in pivotal studies for conditions like narcolepsy. Our ongoing commitment to research and development underscores our strategy to continually enhance patient outcomes and expand our treatment options.
We invite you to join our diverse team of professionals who are passionate about making a difference in the health of people around the world. At Takeda, we understand that our success relies on the talent and dedication of our workforce, fueling our mission to create a healthier future for all.
To stay informed about our financial results, corporate milestones, and ongoing commitment to patients and the planet, we encourage you to explore our investor resources.